Meningococcal Vaccines Market Size, Share, Trends, Growth 2024-2032

According to the report by Expert Market Research (EMR), the global meningococcal vaccines market grew significantly in 2023. Aided by rising prevalence of meningococcal meningitis and rising number of immunisation programmes, the market is projected to further grow between 2024 and 2032.Meningococcal vaccines are used to prevent infection caused by Neisseria meningitidis bacteria. These infections can lead to severe diseases, such as meningitis and sepsis. The vaccines are essential, especially for infants, teenagers, and people with specific health conditions, due to the high risk of infection in these groups.